Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

RestorLife Med vs Super Healthy Rx

Two GLP-1 desks, one scoreboard. We put RestorLife Med and Super Healthy Rx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 28 · Grade B

RestorLife Med

Visit RestorLife Med Full brief →
vs
No. 311 · Grade C

Super Healthy Rx

Visit Super Healthy Rx Full brief →

The verdict

RestorLife Med takes this head-to-head.

RestorLife Med scores 85 to 61 on our six-factor Brief Score — A LegitScript-certified, nationwide desk that trades a premium sticker for accreditation and clean disclosure.

That doesn't make Super Healthy Rx a bad call — it's best for readers who want pending product verification. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
84
48
Supply Reliability
86
66
Transparency
86
72
Access Breadth
86
50
Clinical Oversight
86
76
Track Record
81
54
RestorLife MedBrief Score 85 · 61Super Healthy Rx

Price, coverage & the tracker

RestorLife MedSuper Healthy Rx
Brief Score85/100 (B)61/100 (C)
Semaglutide$299/moFrom $299/mo (starting dose, compounded)
Tirzepatide$399/moFrom $399/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

RestorLife Med: $299 sema / $399 tirz nationwide; LegitScript-certified.

Super Healthy Rx: New to the tracker on 1 August 2026. The published line reads From $299/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.